Condition 101 About Rommen Mueller Sybert Syndrome

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Rommen Mueller Sybert Syndrome

Latest Advances On Rommen Mueller Sybert Syndrome

  • Condition: Giant Cell Lesions
  • Journal: Birth defects research
  • Treatment Used: Surgery and Interferon Alpha-2a Therapy
  • Number of Patients: 1
  • Published —
In this study, researchers sought to determine the best treatment for giant cell lesions due to Noonan syndrome.
  • Condition: Noonan Syndrome (NS)
  • Journal: Pediatric endocrinology reviews : PER
  • Treatment Used: Recombinant Growth Hormone (rhGH)
  • Number of Patients: 0
  • Published —
This review of the literature examined recombinant growth hormone (rhGH) therapy in the treatment of Noonan syndrome (NS), a genetic disorder.

Clinical Trials For Rommen Mueller Sybert Syndrome

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 35
  • Start Date: August 4, 2020
Vosoritide for Selected Genetic Causes of Short Stature
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: February 26, 2018
Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)